{"id":"W1525555980","doi":"10.1038/leu.2015.168","title":"BCR-ABL1 mutation development during first-line treatment with dasatinib or imatinib for chronic myeloid leukemia in chronic phase","year":2015,"lang":"en","type":"article","venue":"Leukemia","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Dasatinib; Imatinib; Medicine; Nilotinib; Internal medicine; Myeloid leukemia; Tyrosine-kinase inhibitor; Oncology; Imatinib mesylate; Mutation; Biology; Cancer; Genetics","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001174083,0.0001363824,0.0004420263,0.0001940247,0.0002923247,0.0004011241,0.0001723407,0.0002772355,0.001326337],"category_scores_gemma":[0.001108146,0.00009690523,0.0002796054,0.0003474703,0.0002976845,0.0002979582,0.0002152961,0.000461453,0.0001928418],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000498144,"about_ca_system_score_gemma":0.0005521213,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000405248,"about_ca_topic_score_gemma":0.001934542,"domain_scores_codex":[0.999289,0.000259054,0.00006976166,0.0001340623,0.0001533211,0.00009471594],"domain_scores_gemma":[0.9991709,0.0001805968,0.0004425587,0.00004619429,0.00004420637,0.0001155548],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.09328684,0.003775668,0.5143471,0.001906811,0.001051317,0.001090203,0.0006589685,0.00114464,0.06957808,0.0007497782,0.004156165,0.3082544],"study_design_scores_gemma":[0.008261405,0.04478526,0.9041885,0.0001463895,0.0004891302,0.003748981,0.0002345552,0.0007718555,0.01788524,0.0004255331,0.0190224,0.00004077883],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9949872,0.001927876,0.0002277203,0.0000625897,0.00001248539,0.0002404153,0.0007818294,0.000008588108,0.001751334],"genre_scores_gemma":[0.9972569,0.0006261407,0.0002327642,0.00008747817,0.00001718307,0.0001586961,0.001032426,0.00000301467,0.0005853626],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001326337,"threshold_uncertainty_score":0.006209195,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04711676767517604,"score_gpt":0.3224659356603377,"score_spread":0.2753491679851617,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}